Ascendis Health Limited

Ascendis Health Limited

Share · ZAE000185005 (XJSE)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Ascendis Health Limited
No Price
Share Float & Liquidity
Free Float 99,95 %
Shares Float 625,75 M
Shares Outstanding 626,05 M
Company Profile for Ascendis Health Limited Share
Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Hungary, Romania, and internationally. The company operates through Consumer Health, Pharma, and Medical segments. It offers body and skin products; and natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Nimue, Scitec, Solal, and Vitaforce brand names. The company also provides medical devices, and diagnostic laboratory equipment and consumables for operating theatres, ICUs, trauma units, maternity and general wards, radiology, pathology labs, research and science institutes, etc.; generic pharmaceutical products, antineoplastic agents, antivirals, aromatase inhibitors, anti-infectives; and products for the nervous system, cardiovascular system, dermatological products, and antimalarials, as well as other therapeutic products under the Pharmachem, Reuterina, Sinucon, Clonam, Phlexy, Surgical Innovations, RCA, and The Scientific Group brands. In addition, it exports its products. The company serves pharmacies, retailers, beauticians, and doctors. Ascendis Health Limited was incorporated in 2008 and is based in Johannesburg, South Africa.

Company Data

Name Ascendis Health Limited
Company Ascendis Health Limited
Website https://www.ascendishealth.com
Primary Exchange XJSE JSE
ISIN ZAE000185005
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO A. Carl Neethling
Market Capitalization 576 Mio
Country South Africa
Currency ZAc
Employees 3,2 T
Address 31 Georgian Crescent East, 2191 Johannesburg
IPO Date 2013-11-22
Dividends from 'Ascendis Health Limited'
Ex-Date Dividend per Share
10.05.2017 11,00 ZAC
30.11.2016 12,00 ZAC
09.05.2016 9,38 ZAC
30.11.2015 10,86 ZAC
11.05.2015 7,90 ZAC
08.12.2014 14,81 ZAC

Stock Splits

Date Split
10.08.2022 253:250
20.07.2016 1013:1000

Ticker Symbols

Name Symbol
JSE ASC.JO
More Shares
Investors who hold Ascendis Health Limited also have the following shares in their portfolio:
Fidelity Disruptors ETF
Fidelity Disruptors ETF ETF
Footway Group AB (publ)
Footway Group AB (publ) Share